Visa has begun piloting a new way for businesses to send money to freelancers, creators and gig workers by paying directly into stablecoin wallets, according to company statements and industry reports. The move aims to cut the time it takes for people to access their earnings and to offer an alternative to bank or card […]Visa has begun piloting a new way for businesses to send money to freelancers, creators and gig workers by paying directly into stablecoin wallets, according to company statements and industry reports. The move aims to cut the time it takes for people to access their earnings and to offer an alternative to bank or card […]

Visa Taps Stablecoins To Eliminate Payment Delays For Creators And Gig Workers

Visa has begun piloting a new way for businesses to send money to freelancers, creators and gig workers by paying directly into stablecoin wallets, according to company statements and industry reports. The move aims to cut the time it takes for people to access their earnings and to offer an alternative to bank or card payments.

Visa Stablecoin Pilot

According to Visa, the pilot will let firms fund payouts in fiat while the recipient receives a USD-pegged stablecoin such as USDC in their crypto wallet. Recipients will still need to complete KYC and AML checks, and platforms must integrate the required rails to convert fiat into stablecoins before sending funds.

Reports have disclosed that the program is being tested within Visa Direct — the company’s money-movement service that already reaches over 195 countries and territories.

Speed And Scale

Faster transfers are the big selling point. Where bank wires or other rails can take days, Visa says stablecoin transfers can land in wallets in minutes. That difference matters for creators who need cash quickly to pay bills or buy services.

According to Visa’s own research cited with the pilot, 57% of digital creators put “instant access” among their top reasons for choosing certain payout methods.

Visa also noted that Visa Direct processes billions of transactions annually and that broader availability could follow in the second half of 2026 after client onboarding and regulatory checks.

How Freelancers Benefit

For people working across borders, receiving pay in a USD-pegged stablecoin can reduce exposure to local currency swings and avoid slow local banking systems. Recipients can choose to hold the stablecoin, convert it to local currency through a crypto exchange, or transfer it into a bank account where that option is available.

This flexibility could be especially useful in markets with weak banking infrastructure or currency controls. Some creators and gig workers, though, will prefer traditional payouts. Adoption is not automatic.

Practical Hurdles For Adoption

Wallet setup and user knowledge remain barriers. Many recipients do not hold compatible wallets or are unsure how to manage stablecoins, custody keys, and conversions.

Platforms must also decide who bears conversion fees and how to present the choice to payees. Integration work is required on the business side to securely convert fiat to USDC and to manage on-chain settlement, without introducing unnecessary risk to customers.

Featured image from Unsplash, chart from TradingView

Market Opportunity
Suilend Logo
Suilend Price(SEND)
$0.182
$0.182$0.182
-0.32%
USD
Suilend (SEND) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale

5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale

BullZilla, World Liberty Financial, MoonBull, La Culex, and Polkadot (DOT) are taking the spotlight among emerging and established crypto projects […] The post 5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale appeared first on Coindoo.
Share
Coindoo2025/10/18 08:15
Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26